Drug: EFAVIRENZ Injury: Maternal exposure during pregnancy Quarter: 2016Q3
Total Records: 26 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
118531922 | EFAVIRENZ | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 18.00 YR | F | 0 | 20160825 | US |
118812352 | EFAVIRENZ | Maternal exposure during pregnancy | MERCK | 29.00 YR | F | 0 | 20160805 | US |
118830632 | EFAVIRENZ | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 27.00 YR | F | 0 | 20160721 | PT |
127359921 | EFAVIRENZ | Maternal exposure during pregnancy | BRISTOL MYERS SQUIBB | 29.00 YR | F | 0 | 20160913 | FR |
127553481 | EFAVIRENZ | Maternal exposure during pregnancy | SANDOZ | 0.00 | F | 0 | 20160916 | US |
127894521 | EFAVIRENZ | Maternal exposure during pregnancy | GILEAD | 37.00 YR | F | 66 KG | 20160928 | UG |
Total Records: 26 Number of Pages: 2